Silva, A.A.R.; Cardoso, M.R.; Oliveira, D.C.d.; Godoy, P.; Talarico, M.C.R.; Gutiérrez, J.M.; Rodrigues Peres, R.M.; de Carvalho, L.M.; Miyaguti, N.A.d.S.; Sarian, L.O.;
et al. Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 2024, 16, 2473.
https://doi.org/10.3390/cancers16132473
AMA Style
Silva AAR, Cardoso MR, Oliveira DCd, Godoy P, Talarico MCR, Gutiérrez JM, Rodrigues Peres RM, de Carvalho LM, Miyaguti NAdS, Sarian LO,
et al. Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer. Cancers. 2024; 16(13):2473.
https://doi.org/10.3390/cancers16132473
Chicago/Turabian Style
Silva, Alex Ap. Rosini, Marcella R. Cardoso, Danilo Cardoso de Oliveira, Pedro Godoy, Maria CecÃlia R. Talarico, Junier Marrero Gutiérrez, Raquel M. Rodrigues Peres, Lucas M. de Carvalho, Natália Angelo da Silva Miyaguti, Luis O. Sarian,
and et al. 2024. "Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer" Cancers 16, no. 13: 2473.
https://doi.org/10.3390/cancers16132473
APA Style
Silva, A. A. R., Cardoso, M. R., Oliveira, D. C. d., Godoy, P., Talarico, M. C. R., Gutiérrez, J. M., Rodrigues Peres, R. M., de Carvalho, L. M., Miyaguti, N. A. d. S., Sarian, L. O., Tata, A., Derchain, S. F. M., & Porcari, A. M.
(2024). Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer. Cancers, 16(13), 2473.
https://doi.org/10.3390/cancers16132473